Parkinson’s disease is mostly known for motor control problems, but a significant number of patients who have the condition also experience cognitive decline.
A new study from University of Arizona researchers shows there may be a path to treatment.
The key is a protein called PNA5. The study showed treatments with the protein reversed cognitive dysfunction in mice by using object recognition and mazes.
It was able to do so by targeting inflammation in the brain. While inflammation is part of the immune system’s response to fight infections, there’s potential for harm.
“It can also become maladaptive in certain situations and that's kind of what happens in Parkinson's disease is that these immune cells called microglia are in fact have become maladaptive, and they go into the supercharge state we call it," said UA professor and study co-author Lalitha Madhavan.
She said she’s hopeful, as a similar drug using the protein is also in clinical trials treating vascular dementia. The study was published in the journal Experimental Neurology.
-
The Arizona Department of Health Services has adopted a policy affirming tribal sovereignty over health data. -
Published by Penguin Random House, Café Gozhóó executive chef Nephi Craig’s hardcover is anything but a cookbook. -
Pinal and Maricopa counties confirmed new cases this week. And Yavapai County on Wednesday confirmed its first measles case of 2026. -
A University of Arizona materials scientist has been awarded a major grant to develop a new generation of drug delivery systems that can hide from the body’s immune system by mimicking the behavior of red blood cells. -
Maricopa County is working to prevent overdose deaths related to extreme heat this summer through increased access to opioid reversal medication.
